Literature DB >> 9875673

Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity.

L F Krist1, M Kerremans, D M Broekhuis-Fluitsma, I L Eestermans, S Meyer, R H Beelen.   

Abstract

The role that milky spots in the greater omentum play in tumour cell spread in the peritoneal cavity is presently not fully understood. To study whether intraperitoneally injected tumour cells appear preferentially in milky spots of the greater omentum and to study the changes in the greater omentum, and especially in the cell population of milky spots after tumour cell infiltration, the following study was performed. A detailed temporal sequences of changes in morphology and cellular composition in milky spots of the greater omentum of Wag/Rij rats 5, 15, 30, 60 min, 2, 4, 8, 16, 24 h, 2, 4, 8 days and 2 and 4 weeks after intraperitoneal administration of 2.0 x 10(6) CC 531 tumour cells was investigated by light microscopy and electron microscopy (pre-embedding labelling). Our data showed that the milky spots in the greater omentum were the sites to which tumour cells migrated preferentially from the peritoneal cavity. The tumour cells infiltrated the milky spots and formed clusters within. The cellular population in milky spots reacted by a very rapid influx of young macrophages during the first hour and an increase of the total number of cells (P < 0.01). After 4 h tumour cells were also located on the greater omentum outside the area of the milky spots. Around these tumour cell deposits, new milky spots are formed, which increased the total number of milky spots. The cells present in milky spots are not capable of reversing the growth of tumours and finally a solid omental cake of tumour cells is formed.

Entities:  

Mesh:

Year:  1998        PMID: 9875673     DOI: 10.1007/s002620050522

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

1.  Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models.

Authors:  Robert Clark; Venkatesh Krishnan; Michael Schoof; Irving Rodriguez; Betty Theriault; Marina Chekmareva; Carrie Rinker-Schaeffer
Journal:  Am J Pathol       Date:  2013-08       Impact factor: 4.307

Review 2.  Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.

Authors:  H Chkourko Gusky; J Diedrich; O A MacDougald; I Podgorski
Journal:  Obes Rev       Date:  2016-07-19       Impact factor: 9.213

3.  Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens.

Authors:  Javier Rangel-Moreno; Juan E Moyron-Quiroz; Damian M Carragher; Kim Kusser; Louise Hartson; Amy Moquin; Troy D Randall
Journal:  Immunity       Date:  2009-05-07       Impact factor: 31.745

Review 4.  The omentum: anatomical, metabolic, and surgical aspects.

Authors:  Danielle Collins; Aisling M Hogan; Donal O'Shea; Des C Winter
Journal:  J Gastrointest Surg       Date:  2009-03-17       Impact factor: 3.452

5.  Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells.

Authors:  Premkumar Vummidi Giridhar; Holly M Funk; Catherine A Gallo; Aleksey Porollo; Carol A Mercer; David R Plas; Angela F Drew
Journal:  Clin Exp Metastasis       Date:  2011-09-02       Impact factor: 5.150

6.  Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  J Interferon Cytokine Res       Date:  2015-10-02       Impact factor: 2.607

7.  The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa shift peritoneal milky spot macrophages towards an M1 phenotype to dampen peritoneal dissemination.

Authors:  Zhi-Feng Miao; Ting-Ting Zhao; Feng Miao; Zhen-Ning Wang; Ying-Ying Xu; Xiao-Yun Mao; Jian Gao; Jian-Hua Wu; Xing-Yu Liu; Yi You; Hao Xu; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2014-01-03

8.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.

Authors:  Yueying Liu; Matthew N Metzinger; Kyle A Lewellen; Stephanie N Cripps; Kyle D Carey; Elizabeth I Harper; Zonggao Shi; Laura Tarwater; Annie Grisoli; Eric Lee; Ania Slusarz; Jing Yang; Elizabeth A Loughran; Kaitlyn Conley; Jeff J Johnson; Yuliya Klymenko; Lana Bruney; Zhong Liang; Norman J Dovichi; Bentley Cheatham; W Matthew Leevy; M Sharon Stack
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

Review 10.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.